Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  HIV Infection

  Free Subscription


17.06.2019

1 AIDS
5 AIDS Res Hum Retroviruses
1 Antimicrob Agents Chemother
4 Clin Infect Dis
12 J Acquir Immune Defic Syndr
1 J Clin Immunol
1 J Immunol
5 J Infect Dis
2 J Med Virol
3 J Virol
8 JAMA
1 Lancet
1 Lancet Child Adolesc Health
2 Lancet HIV
1 Lancet Infect Dis
2 Neurology
3 Pediatr Infect Dis J
1 PLoS Biol
2 PLoS Comput Biol
2 PLoS Med
7 PLoS One
1 PLoS Pathog
2 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. RADFORD M, Parks DC, Ferrante S, Punekar Y, et al
    Dolutegravir and lamivudine vs other antiviral regimens in HIV-1 treatment-naive patients: a systematic review and network meta-analysis.
    AIDS. 2019 Jun 7. doi: 10.1097/QAD.0000000000002285.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  2. TOVAR-SALAZAR A, McKhann A, Chen H, Bosch RJ, et al
    Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2019 Jun 10. doi: 10.1089/AID.2019.0053.
    PubMed     Text format     Abstract available

  3. SHEN J, Liberty A, Shiau S, Strehlau R, et al
    Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-infection on Antiretroviral Therapy.
    AIDS Res Hum Retroviruses. 2019 Jun 10. doi: 10.1089/AID.2018.0182.
    PubMed     Text format     Abstract available

  4. ZHANG M, Li H, Zou Y, Fu Y, et al
    Identification of three HIV-1 unique (B/C) recombinant forms in Shaanxi, China.
    AIDS Res Hum Retroviruses. 2019 Jun 12. doi: 10.1089/AID.2019.0108.
    PubMed     Text format     Abstract available

  5. GE Z, Liu D, Lv B, Liang Y, et al
    Genomic Characterization of a Novel HIV-1 CRF01_AE/07_BC Recombinant Virus From a Married Men Who Have Sex with Men in Tianjin, China.
    AIDS Res Hum Retroviruses. 2019 Jun 12. doi: 10.1089/AID.2019.0093.
    PubMed     Text format     Abstract available

  6. LI K, Liu M, Li J, Dong A, et al
    Genomic Characterization of a Novel HIV-1 Second-Generation recombinant form (CRF01_AE/B) From a Men Who Have Sex with Men in Guangxi Zhuang Autonomous Region, China.
    AIDS Res Hum Retroviruses. 2019 Jun 12. doi: 10.1089/AID.2019.0149.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  7. MALLAYASAMY S, Chaturvedula A, Fossler MJ, Sale M, et al
    Tenofovir plasma concentration from pre-exposure prophylaxis (PrEP) at the time of potential HIV exposure: a population pharmacokinetic modeling and simulation study involving serodiscordant couples in East Africa.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00446.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  8. HAVENS PL, Perumean-Chaney SE, Patki A, Cofield SS, et al
    Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.
    Clin Infect Dis. 2019 Jun 8. pii: 5513182. doi: 10.1093.
    PubMed     Text format     Abstract available

  9. WAKE RM, Govender NP, Omar T, Nel C, et al
    Cryptococcal-related mortality despite fluconazole pre-emptive treatment in a cryptococcal antigen (CrAg) screen-and-treat programme.
    Clin Infect Dis. 2019 Jun 8. pii: 5513150. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. WALKER NF, Opondo C, Meintjes G, Jhilmeet N, et al
    Invariant Natural Killer T cell dynamics in HIV-associated tuberculosis.
    Clin Infect Dis. 2019 Jun 12. pii: 5514487. doi: 10.1093.
    PubMed     Text format     Abstract available

  11. MALIK AA, Fuad J, Siddiqui S, Amanullah F, et al
    TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen.
    Clin Infect Dis. 2019 Jun 12. pii: 5514486. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  12. EL-SADR WM, Beauchamp G, Hall HI, Torian LV, et al
    Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study.
    J Acquir Immune Defic Syndr. 2019;81:300-303.
    PubMed     Text format     Abstract available

  13. SHABA F, Offorjebe OA, Phiri K, Lungu E, et al
    Perceived Acceptability of a Facility-Based HIV Self-Test Intervention in Outpatient Waiting Spaces Among Adult Outpatients in Malawi: A Formative Study.
    J Acquir Immune Defic Syndr. 2019;81:e92-e94.
    PubMed     Text format    

  14. LAM JO, Hurley LB, Udaltsova N, Alexeeff SE, et al
    Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting.
    J Acquir Immune Defic Syndr. 2019;81:284-291.
    PubMed     Text format     Abstract available

  15. CHAPIN-BARDALES J, Rosenberg ES, Sullivan PS, Jenness SM, et al
    Trends in Number and Composition of Sex Partners Among Men Who Have Sex With Men in the United States, National HIV Behavioral Surveillance, 2008-2014.
    J Acquir Immune Defic Syndr. 2019;81:257-265.
    PubMed     Text format     Abstract available

  16. ROTHENBERGER M, Nganou-Makamdop K, Kityo C, Ssali F, et al
    Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues.
    J Acquir Immune Defic Syndr. 2019;81:355-360.
    PubMed     Text format     Abstract available

  17. NOEL N, Gominet M, Meyer L, Boufassa F, et al
    Cardiovascular events in the French ANRS HIV controller cohort.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002108.
    PubMed     Text format    

  18. JOHNSON KA, Hessol NA, Kohn R, Nguyen TQ, et al
    HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002107.
    PubMed     Text format     Abstract available

  19. MORSICA G, Galli L, Bossolasco S, Bagaglio S, et al
    OUTCOME OF ACUTE HEPATITIS B VIRUS INFECTION IN HIV-1 INFECTED PATIENTS: POSSIBLE FACTORS ASSOCIATED WITH RESOLUTION OR CHRONICITY.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002106.
    PubMed     Text format     Abstract available

  20. WEINBERG A, Huo Y, Kacanek D, Patel K, et al
    Markers of Spontaneuous Preterm Delivery in Women living with HIV: Relationship with Protease Inhibitors and Vitamin D.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002111.
    PubMed     Text format     Abstract available

  21. BONACCI RA, Bradley H, Rosenberg ES, Holtgrave DR, et al
    Evaluating HIV Transmission Rates for the US National HIV/AIDS Strategy, 2010-2015.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002113.
    PubMed     Text format    

  22. CHAN P, Dumrongpisutikul N, Subra C, Colby DJ, et al
    Neurosyphilis during Acute HIV Infection: A CNS Immunologic and Virologic Characterization.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002114.
    PubMed     Text format    

  23. POTEAT T, Wirtz A, Malik M, Cooney E, et al
    A Gap Between Willingness and Uptake: Findings from Mixed Methods Research on HIV Prevention among Black and Latina Transgender Women.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002112.
    PubMed     Text format     Abstract available


    J Clin Immunol

  24. LIEW WK, Thoon KC, Chong CY, Tan NWH, et al
    Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    J Clin Immunol. 2019 Jun 8. pii: 10.1007/s10875-019-00652.
    PubMed     Text format     Abstract available


    J Immunol

  25. NATESAMPILLAI S, Paim AC, Cummins NW, Chandrasekar AP, et al
    TRAILshort Protects against CD4 T Cell Death during Acute HIV Infection.
    J Immunol. 2019 Jun 12. pii: jimmunol.1900271. doi: 10.4049/jimmunol.1900271.
    PubMed     Text format     Abstract available


    J Infect Dis

  26. ROH ME, Tessema SK, Murphy M, Nhlabathi N, et al
    High genetic diversity of Plasmodium falciparum in the low transmission setting of the Kingdom of Eswatini.
    J Infect Dis. 2019 Jun 13. pii: 5514501. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. WANGDAHL A, Wyss K, Saduddin D, Bottai M, et al
    Severity of Plasmodium falciparum and non-falciparum malaria in travelers and migrants: a nationwide observational study over two decades in Sweden.
    J Infect Dis. 2019 Jun 6. pii: 5512705. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. MUGWANYA KK, Baeten JM
    Next-Generation Pre-Exposure Prophylaxis: Choices for Effective HIV Prevention.
    J Infect Dis. 2019 Jun 7. pii: 5513001. doi: 10.1093.
    PubMed     Text format    

  29. MARKOWITZ M, Gettie A, St Bernard L, Andrews CD, et al
    Title: Once-weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques from Intrarectal SHIV109CP3 Challenge.
    J Infect Dis. 2019 Jun 7. pii: 5513016. doi: 10.1093.
    PubMed     Text format     Abstract available

  30. SIEDNER MJ, Bwana MB, Asiimwe S, Amanyire G, et al
    Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study.
    J Infect Dis. 2019 Jun 12. pii: 5514246. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  31. WANG SM, Huang KJ, Wang CT
    Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.
    J Med Virol. 2019 Jun 14. doi: 10.1002/jmv.25518.
    PubMed     Text format     Abstract available

  32. GIACOMELLI A, Fabbiani M, De Benedetto I, Nozza S, et al
    Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.
    J Med Virol. 2019 Jun 14. doi: 10.1002/jmv.25517.
    PubMed     Text format     Abstract available


    J Virol

  33. MILLER RL, Ponte R, Jones BR, Kinloch NN, et al
    HIV diversity and genetic compartmentalization in blood and testes during suppressive antiretroviral therapy.
    J Virol. 2019 Jun 12. pii: JVI.00755-19. doi: 10.1128/JVI.00755.
    PubMed     Text format     Abstract available

  34. ZOLLA-PAZNER S, Gilbert PB
    REVISITING THE CORRELATE OF REDUCED HIV INFECTION RISK IN THE RV144 VACCINE TRIAL.
    J Virol. 2019 Jun 12. pii: JVI.00629-19. doi: 10.1128/JVI.00629.
    PubMed     Text format     Abstract available

  35. KOMA T, Kotani O, Miyakawa K, Ryo A, et al
    Allosteric regulation of HIV-1 capsid structure for Gag assembly, virion production, and viral infectivity by a disordered interdomain linker.
    J Virol. 2019 Jun 12. pii: JVI.00381-19. doi: 10.1128/JVI.00381.
    PubMed     Text format     Abstract available


    JAMA

  36. JIN J
    Can HIV Infection Be Prevented With Medication?
    JAMA. 2019;321:2252.
    PubMed     Text format    

  37. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;321:2203-2213.
    PubMed     Text format     Abstract available

  38. CHOU R, Evans C, Hoverman A, Sun C, et al
    Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;321:2214-2230.
    PubMed     Text format     Abstract available

  39. SCOTT H, Volberding PA
    HIV Screening and Preexposure Prophylaxis Guidelines: Following the Evidence.
    JAMA. 2019;321:2172-2174.
    PubMed     Text format    

  40. CHOU R, Dana T, Grusing S, Bougatsos C, et al
    Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019 Jun 11. pii: 2735343. doi: 10.1001/jama.2019.2592.
    PubMed     Text format     Abstract available

  41. SELPH SS, Bougatsos C, Dana T, Grusing S, et al
    Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019 Jun 11. pii: 2735344. doi: 10.1001/jama.2019.2593.
    PubMed     Text format     Abstract available

  42. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019 Jun 11. pii: 2735345. doi: 10.1001/jama.2019.6587.
    PubMed     Text format     Abstract available

  43. JIN J
    Who Should Be Screened for HIV Infection?
    JAMA. 2019 Jun 11. pii: 2735342. doi: 10.1001/jama.2019.6919.
    PubMed     Text format    


    Lancet

  44. GREEN A
    HIV epidemic in children in Pakistan raises concern.
    Lancet. 2019;393:2288.
    PubMed     Text format    


    Lancet Child Adolesc Health

  45. TOMLINSON M, Rotheram-Borus MJ
    HIV, children, and obesity: too soon for conclusions?
    Lancet Child Adolesc Health. 2019;3:e9.
    PubMed     Text format    


    Lancet HIV

  46. HOORNENBORG E, Coyer L, Achterbergh RCA, Matser A, et al
    Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Lancet HIV. 2019 Jun 6. pii: S2352-3018(19)30136.
    PubMed     Text format     Abstract available

  47. SCOTT HM, Buchbinder SP
    STIs: an unintended consequence of improved sexual health?
    Lancet HIV. 2019 Jun 6. pii: S2352-3018(19)30140.
    PubMed     Text format    


    Lancet Infect Dis

  48. SUAREZ I, Maria Funger S, Jung N, Lehmann C, et al
    Severe disseminated tuberculosis in HIV-negative refugees.
    Lancet Infect Dis. 2019 Jun 7. pii: S1473-3099(19)30162.
    PubMed     Text format     Abstract available


    Neurology

  49. CYSIQUE LA, Messinis L, Albert SM
    Could excess body weight be good for cognitive health in chronic HIV infection?
    Neurology. 2019 Jun 14. pii: WNL.0000000000007769.
    PubMed     Text format    

  50. RUBIN LH, Gustafson D, Hawkins KL, Zhang L, et al
    Midlife adiposity predicts cognitive decline in the prospective Multicenter AIDS Cohort Study.
    Neurology. 2019 Jun 14. pii: WNL.0000000000007779.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  51. IROH TAM PY, Wiens MO, Moschovis PP
    Re: "Investment Long Overdue in Primary Studies of HIV-exposed Uninfected Infant Infectious Morbidity".
    Pediatr Infect Dis J. 2019;38:e165.
    PubMed     Text format    

  52. SLOGROVE AL, Powis KM
    Investment Long Overdue in Primary Studies of HIV-exposed Uninfected Infant Infectious Morbidity.
    Pediatr Infect Dis J. 2019;38:e164-e165.
    PubMed     Text format    

  53. SMITH S, Govender K, Moodley P, La Russa P, et al
    Impact of Shifts to Birth Testing on Early Infant Diagnosis Program Outcomes in KwaZulu-Natal, South Africa.
    Pediatr Infect Dis J. 2019;38:e138-e142.
    PubMed     Text format     Abstract available


    PLoS Biol

  54. WARREN CJ, Meyerson NR, Dirasantha O, Feldman ER, et al
    Selective use of primate CD4 receptors by HIV-1.
    PLoS Biol. 2019;17:e3000304.
    PubMed     Text format     Abstract available


    PLoS Comput Biol


  55. Correction: Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection.
    PLoS Comput Biol. 2019;15:e1007138.
    PubMed     Text format     Abstract available

  56. GOODSELL DS, Jewett A, Olson AJ, Forli S, et al
    Integrative modeling of the HIV-1 ribonucleoprotein complex.
    PLoS Comput Biol. 2019;15:e1007150.
    PubMed     Text format     Abstract available


    PLoS Med

  57. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Nagi R, et al
    Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.
    PLoS Med. 2019;16:e1002819.
    PubMed     Text format     Abstract available

  58. TYMEJCZYK O, Brazier E, Yiannoutsos CT, Vinikoor M, et al
    Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
    PLoS Med. 2019;16:e1002822.
    PubMed     Text format     Abstract available


    PLoS One

  59. PASTOR L, Langhorst J, Schroder D, Casellas A, et al
    Different pattern of stool and plasma gastrointestinal damage biomarkers during primary and chronic HIV infection.
    PLoS One. 2019;14:e0218000.
    PubMed     Text format     Abstract available

  60. KUMWENDA MK, Corbett EL, Choko AT, Chikovore J, et al
    Post-test adverse psychological effects and coping mechanisms amongst HIV self-tested individuals living in couples in urban Blantyre, Malawi.
    PLoS One. 2019;14:e0217534.
    PubMed     Text format     Abstract available

  61. ZAMANIAN M, Zolala F, Haghdoost AA, Haji-Maghsoudi S, et al
    Methodological considerations in using the Network Scale Up (NSU) for the estimation of risky behaviors of particular age-gender groups: An example in the case of intentional abortion.
    PLoS One. 2019;14:e0217481.
    PubMed     Text format     Abstract available

  62. KUMAR U, Pollard L, Campbell L, Yurdakul S, et al
    Specialist follow-up contraceptive support after abortion-Impact on effective contraceptive use at six months and subsequent abortions: A randomised controlled trial.
    PLoS One. 2019;14:e0217902.
    PubMed     Text format     Abstract available

  63. KJERULFF MADSEN F, Holm-Larsen CE, Wu C, Rogathi J, et al
    Intimate partner violence and subsequent premature termination of exclusive breastfeeding: A cohort study.
    PLoS One. 2019;14:e0217479.
    PubMed     Text format     Abstract available

  64. NDLOVU KCZ, Chikobvu P, Mofokeng T, Gounden V, et al
    Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis.
    PLoS One. 2019;14:e0218156.
    PubMed     Text format     Abstract available

  65. GALLAY P, Ure D, Bobardt M, Chatterji U, et al
    The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice.
    PLoS One. 2019;14:e0217433.
    PubMed     Text format     Abstract available


    PLoS Pathog

  66. ZHOU P, Wang H, Fang M, Li Y, et al
    Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies.
    PLoS Pathog. 2019;15:e1007819.
    PubMed     Text format     Abstract available


    Vaccine

  67. LOH FK, Nathan S, Chow SC, Fang CM, et al
    Vaccination challenges and strategies against long-lived Toxoplasma gondii.
    Vaccine. 2019 Jun 8. pii: S0264-410X(19)30730.
    PubMed     Text format     Abstract available

  68. ANDRASIK M, Grove D, Broder G, Scott H, et al
    A descriptive analysis of transgender participants in phase 1-2a trials of the HIV Vaccine Trials Network (HVTN) in the United States and Peru.
    Vaccine. 2019 Jun 5. pii: S0264-410X(19)30630.
    PubMed     Text format     Abstract available


    Virology

  69. MEADOR LR, Kessans SA, Kilbourne J, Kibler KV, et al
    Corrigendum to "A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles" [Virology 507 (2017) 242-256].
    Virology. 2019 Jun 6. pii: S0042-6822(19)30139.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: